Cargando…

Current Overview of Treatment for Metastatic Bone Disease

The number of patients with bone metastasis increases as medical management and surgery improve the overall survival of patients with cancer. Bone metastasis can cause skeletal complications, including bone pain, pathological fractures, spinal cord or nerve root compression, and hypercalcemia. Befor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukamoto, Shinji, Kido, Akira, Tanaka, Yasuhito, Facchini, Giancarlo, Peta, Giuliano, Rossi, Giuseppe, Mavrogenis, Andreas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482272/
https://www.ncbi.nlm.nih.gov/pubmed/34590591
http://dx.doi.org/10.3390/curroncol28050290
_version_ 1784576869184569344
author Tsukamoto, Shinji
Kido, Akira
Tanaka, Yasuhito
Facchini, Giancarlo
Peta, Giuliano
Rossi, Giuseppe
Mavrogenis, Andreas F.
author_facet Tsukamoto, Shinji
Kido, Akira
Tanaka, Yasuhito
Facchini, Giancarlo
Peta, Giuliano
Rossi, Giuseppe
Mavrogenis, Andreas F.
author_sort Tsukamoto, Shinji
collection PubMed
description The number of patients with bone metastasis increases as medical management and surgery improve the overall survival of patients with cancer. Bone metastasis can cause skeletal complications, including bone pain, pathological fractures, spinal cord or nerve root compression, and hypercalcemia. Before initiation of treatment for bone metastasis, it is important to exclude primary bone malignancy, which would require a completely different therapeutic approach. It is essential to select surgical methods considering the patient’s prognosis, quality of life, postoperative function, and risk of postoperative complications. Therefore, bone metastasis treatment requires a multidisciplinary team approach, including radiologists, oncologists, and orthopedic surgeons. Recently, many novel palliative treatment options have emerged for bone metastases, such as stereotactic body radiation therapy, radiopharmaceuticals, vertebroplasty, minimally invasive spine stabilization with percutaneous pedicle screws, acetabuloplasty, embolization, thermal ablation techniques, electrochemotherapy, and high-intensity focused ultrasound. These techniques are beneficial for patients who may not benefit from surgery or radiotherapy.
format Online
Article
Text
id pubmed-8482272
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84822722021-10-01 Current Overview of Treatment for Metastatic Bone Disease Tsukamoto, Shinji Kido, Akira Tanaka, Yasuhito Facchini, Giancarlo Peta, Giuliano Rossi, Giuseppe Mavrogenis, Andreas F. Curr Oncol Review The number of patients with bone metastasis increases as medical management and surgery improve the overall survival of patients with cancer. Bone metastasis can cause skeletal complications, including bone pain, pathological fractures, spinal cord or nerve root compression, and hypercalcemia. Before initiation of treatment for bone metastasis, it is important to exclude primary bone malignancy, which would require a completely different therapeutic approach. It is essential to select surgical methods considering the patient’s prognosis, quality of life, postoperative function, and risk of postoperative complications. Therefore, bone metastasis treatment requires a multidisciplinary team approach, including radiologists, oncologists, and orthopedic surgeons. Recently, many novel palliative treatment options have emerged for bone metastases, such as stereotactic body radiation therapy, radiopharmaceuticals, vertebroplasty, minimally invasive spine stabilization with percutaneous pedicle screws, acetabuloplasty, embolization, thermal ablation techniques, electrochemotherapy, and high-intensity focused ultrasound. These techniques are beneficial for patients who may not benefit from surgery or radiotherapy. MDPI 2021-08-29 /pmc/articles/PMC8482272/ /pubmed/34590591 http://dx.doi.org/10.3390/curroncol28050290 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tsukamoto, Shinji
Kido, Akira
Tanaka, Yasuhito
Facchini, Giancarlo
Peta, Giuliano
Rossi, Giuseppe
Mavrogenis, Andreas F.
Current Overview of Treatment for Metastatic Bone Disease
title Current Overview of Treatment for Metastatic Bone Disease
title_full Current Overview of Treatment for Metastatic Bone Disease
title_fullStr Current Overview of Treatment for Metastatic Bone Disease
title_full_unstemmed Current Overview of Treatment for Metastatic Bone Disease
title_short Current Overview of Treatment for Metastatic Bone Disease
title_sort current overview of treatment for metastatic bone disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482272/
https://www.ncbi.nlm.nih.gov/pubmed/34590591
http://dx.doi.org/10.3390/curroncol28050290
work_keys_str_mv AT tsukamotoshinji currentoverviewoftreatmentformetastaticbonedisease
AT kidoakira currentoverviewoftreatmentformetastaticbonedisease
AT tanakayasuhito currentoverviewoftreatmentformetastaticbonedisease
AT facchinigiancarlo currentoverviewoftreatmentformetastaticbonedisease
AT petagiuliano currentoverviewoftreatmentformetastaticbonedisease
AT rossigiuseppe currentoverviewoftreatmentformetastaticbonedisease
AT mavrogenisandreasf currentoverviewoftreatmentformetastaticbonedisease